Jiudian Pharmaceutical: Yang Yang plans to reduce his shareholding by not more than 0.031%

Jiudian Pharmaceutical announced that the director and general manager Yang Yang plans to reduce the company's shares by no more than 153,000 shares, accounting for 0.031% of the total share capital of the company, through centralized bidding within 3 months after the disclosure of the announcement. As of the announcement date, Yang Yang held 612,100 shares of the company, accounting for 0.124% of the total share capital of the company. The source of the reduction in shares includes shares obtained through non-trading transfers, shares transferred from capital reserves, and shares granted through equity incentive plans. The reduction price will be determined based on the secondary market price at the time of reduction. The implementation of this reduction plan will not result in a change in the company's control.